ErbB3, a possible prognostic factor of head and neck squamous cell carcinoma
ConclusionsErbB3 overexpression predicts a poor clinical outcome. Sapitinib was shown to be an effective inhibitor in the HNSCC cell line and animal models of cancer but with no statistical significance. Further studies with larger groups are needed to better support these results.
Source: Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology - Category: ENT & OMF Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | ENT & OMF | Genetics | Head and Neck Cancer | HNSCC | Oral Cancer | Oral Cavity Cancer | Pathology | Radiation Therapy | Radiology | Skin Cancer | Squamous Cell Carcinoma | Statistics | Study